Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010)

Gales, Ana Cristina; Castanheira, Mariana; Jones, Ronald N.; Sader, Hélio S.

doi:10.1016/j.diagmicrobio.2012.04.007

Cited by 253 publications

(200 citation statements)

References 17 publications

Supporting

Mentioning

148

Contrasting

Unclassified

Order By: Relevance

“…Microbiología nuestros aislados de P. aeruginosa frente a piperacilina/ tazobactam, ceftazidima, imipenem, meropenem, ciprofloxacina, amikacina y gentamicina fueron menores que las reportadas por el SENTRY para el período entre 2008 y 2010 10 . Tan sólo se observó una mayor resistencia frente a aztreonam y cefepime.…”

Section: Artículo Originalunclassified

Pseudomonas aeruginosa resistente a antimicrobianos en hospitales colombianos

Villa

Cortés

Leal

et al. 2013

Rev. chil. infectol.

View full text Add to dashboard Cite

Section: Artículo Originalunclassified

Pseudomonas aeruginosa resistente a antimicrobianos en hospitales colombianos

Villa

Cortés

Leal

et al. 2013

Rev. chil. infectol.

View full text Add to dashboard Cite

“…The effect of using less efficacious antimicrobial agents on patients suffering from bacterial infections or other diseases is associated with increased costs, length of hospitalization and increase in mortality rates (Gales et al, 2012). This is also true of infections caused by isolates which are resistant to some antimicrobial agents.…”

Section: Introductionmentioning

confidence: 99%

An Assessment of the Efficacy of Ofloxacin Brands on Clinical Isolates of Streptococcus Pneumoniae and Staphylococcus Aureus

Anomohanran

Owhe-Ureghe

2015

MAS

View full text Add to dashboard Cite

It is a common practice for clinicians to administer antimicrobial agents to patients suffering from bacterial infections without recourse to laboratory diagnosis which provides information on the antibiogram of the etiologic agents. This may result to the use of less efficacious drugs that might lead to long time hospitalization, death of patients and/or opportunity for bacterial species to develop resistant to some of these antimicrobial agents. This is the reason why, this study was carried out to determine the efficacy of five (5) brands of Ofloxacin; a typical floroquinolone antibiotic available in most pharmaceutical shops in Nigeria. Clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus were exposed to twofold serial dilution of the antibiotic to determine the minimum inhibitory concentration (MIC). Result shows that the percentage strains of Streptococcus pneumoniae inhibited by the five brands of Ofloxacin investigated were 72, 74, 41, 68 and 76% respectively. Result also shows that the percentage strains of Staphylococcus aureus inhibited by the antimicrobial agent were 81, 85, 52, 79 and 85% respectively. Analysis of the result shows that the efficacy rate of Ofloxacin against Streptococcus pneumoniae and Staphylococcus aureus were 72 and 81% respectively. The result has shown that patients and health care providers can rely on this antimicrobial agent in the treatment of ailments associated with Streptococcus pneumoniae and Staphylococcus aureus in this locality provided the efficacy of the brand to be used is tested.

show abstract

“…Concomitantemente ao seu uso, surgiram os isolados apresentando resistência, como pode ser observado na Figura 2 (Davies, Davies, 2010 (Gales et al, 2012;Girão et al, 2008;Kiffer et al, 2005;Lincopan et al, 2005;2006;Pavez et al, 2009;Rossi, 2011;Sader et al, 2001;Theuretzbacher, 2012). O tratamento de pacientes com infecções hospitalares graves utilizando antibióticos de amplo espectro de atividade, como os carbapenêmicos, deve-se a sua boa permeabilidade através da membrana externa bacteriana e estabilidade frente a muitas β-lactamases (Franco et al, 2010;Fritsche et al, 2005;Gales et al, 2003).…”

Section: O Uso Excessivo De Antibióticos E a Infecção Hospitalarunclassified

“…é responsável por 7,5% das infecções de corrente sanguínea, por 31,2% dos casos de pneumonia e, por 13,8% das infecções da pele e dos tecidos moles (Gales et al, 2012).…”

Section: Pseudomonas Aeruginosaunclassified

Alternativas terapêuticas para o tratamento de infecções por Pseudomonas aeruginosa multirresistentes endêmicas no Brasil.

Turano¹

View full text Add to dashboard Cite

Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010)

Cited by 253 publications

References 17 publications

Pseudomonas aeruginosa resistente a antimicrobianos en hospitales colombianos

Pseudomonas aeruginosa resistente a antimicrobianos en hospitales colombianos

An Assessment of the Efficacy of Ofloxacin Brands on Clinical Isolates of Streptococcus Pneumoniae and Staphylococcus Aureus

Alternativas terapêuticas para o tratamento de infecções por Pseudomonas aeruginosa multirresistentes endêmicas no Brasil.

Contact Info

Product

Resources

About